Literature DB >> 2967857

Restenosis and progression of coronary atherosclerosis after coronary angioplasty.

A Cequier1, R Bonan, J Crépeau, G Coté, P De Guise, P Joly, J Lespérance, D D Waters.   

Abstract

The relation between restenosis and progression of atherosclerosis in other coronary segments after angioplasty was studied in 98 consecutive patients with 110 coronary stenoses successfully treated with angioplasty. At early angiographic restudy (5 +/- 2 months after angioplasty) 37 patients (38%) had restenosis (defined as a stenosis greater than or equal to 50% of the luminal diameter or loss of greater than or equal to 50% of the gain achieved by angioplasty); progression of atherosclerosis was observed in 4 patients with and 7 without restenosis (13 versus 11%, p = NS). Ninety of the 98 patients underwent a late angiographic restudy a mean of 34 +/- 11 months after angioplasty. Late restenosis was found in one patient. Progression of coronary artery disease (defined as a greater than or equal to 20% decrease in the diameter of a vessel initially narrowed by greater than or equal to 50% or a greater than or equal to 30% decrease when the initial stenosis was less than 50%) was examined in relation to restenosis in 85 of the 90 patients. It occurred in 9 of 27 patients with and 22 of 58 patients without restenosis (33 versus 38%, p = NS). Restenosis developed more rapidly than did progression of disease. Diameter stenosis increased from 35 +/- 8 to 73 +/- 11% at the early restudy in lesions with restenosis; in lesions with disease progression it increased from 9 +/- 18 to 20 +/- 28% (p less than 0.001) at the early restudy to 53 +/- 21% (p less than 0.001) at the late restudy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 2967857     DOI: 10.1016/0735-1097(88)90355-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  3 in total

1.  Effect of the final coronary arterial diameter after coronary angioplasty on heart rate variability responses.

Authors:  Mehmet Kanadasi; Gulmira Kudaiberdieva; Ahmet Birand
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-04       Impact factor: 1.468

2.  p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.

Authors:  Jiaojiao Guo; Ning Xie; Geng Li; Yan Zhang; Fengxiang Lv; Sile Guo; Yuanqing Feng; Chun-Mei Cao; Rui-Ping Xiao
Journal:  J Mol Med (Berl)       Date:  2015-04-19       Impact factor: 4.599

3.  Microalbuminuria is no risk factor for restenosis following percutaneous transluminal coronary angioplasty.

Authors:  H Toplak; M Schumacher; B Eber; O Luha; W Klein; G J Krejs
Journal:  Clin Investig       Date:  1992-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.